The biotech sector has taken a bit of a beating, down about 24% this year as measured by the iShares NASDAQ Biotechnology Index ETF, and down about 35% from last year’s peak. And yet, if you zoom out a little further, the biotech sector is up 141% over the last five years, absolutely trouncing the S&P 500.
Can biotech get back to its market-beating ways? I think so.
